We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > LEUKOCARE

News List

Rentschler, Leukocare Extend Service Offering with U.S. Site contractpharma
March 23, 2021
Opens Leukocare’s U.S. development labs and offices at Rentschler's facility in the Greater Boston area, where the two companies will work together.
Leukocare Starts Operations in the US contractpharma
January 12, 2021
Leukocare AG, a German biotechnology company specialized in formulation development for biologics, viral vectors and vaccines, has opened its development laboratories and offices in Milford, MA.
Rentschler and Leukocare Announce Strategic Alliance And Equity Investment b3cnewswire
February 07, 2017
Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried today announced a strategic alliance under which Leukocare will become the specialized technology partner and the exclusive formulation developer for Rentschler’s biopharmaceuticals b